Rapid Micro Biosystems, Inc.
RPID · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.44 | -0.84 | -0.14 | 0.07 |
| FCF Yield | 0.00% | -6.53% | -8.08% | -25.40% |
| EV / EBITDA | -12.06 | -12.80 | -8.84 | -3.25 |
| Quality | ||||
| ROIC | -16.46% | -20.12% | -16.28% | -12.31% |
| Gross Margin | 29.03% | 26.81% | 30.20% | 11.95% |
| Cash Conversion Ratio | 0.79 | 0.82 | 0.80 | 1.03 |
| Growth | ||||
| Revenue 3-Year CAGR | 14.09% | 16.51% | 18.08% | 17.86% |
| Free Cash Flow Growth | 0.00% | -7.27% | 6.23% | -13.42% |
| Safety | ||||
| Net Debt / EBITDA | -0.40 | 1.16 | 1.12 | 1.22 |
| Interest Coverage | 27.27 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.26 | 0.26 | 0.24 | 0.36 |
| Cash Conversion Cycle | 345.08 | 367.27 | 380.24 | 302.09 |